Cancer and COVID-19 vaccines
Information about COVID-19 vaccines for people with cancer is evolving. You may have questions and feel uncertain, frustrated or overwhelmed as vaccines roll out across Canada. At the Canadian Cancer Society (CCS), we’re working to stay up to date with the latest information and recommendations for people with cancer and survivors. We are reviewing research and guidance regularly so that we can continue to keep you informed. We will keep this page updated with new information as we receive it.
Is CCS adopting a mandatory vaccination policy? @(Model.HeadingTag)>
Can I get the COVID-19 vaccine if I have cancer? @(Model.HeadingTag)>
The COVID-19 vaccine is safe for most people with cancer. Talk to your healthcare team about if you should receive the vaccine. They will be able to determine if the benefits outweigh the risks for you. They can also determine which of the approved COVID-19 vaccines is right for you, and the best timing of the first, second and additional doses, based on your unique circumstance.
Vaccines work by stimulating the immune system to produce antibodies to fight a disease. You may be immunosuppressed (have a weak immune system) due to cancer or its treatment. Currently, the COVID-19 vaccine is offered to people who are immunosuppressed and who meet the required age for use. But the vaccine may not be able to stimulate your immune system well enough to protect against COVID-19.
Not everyone with cancer is immunosuppressed. Talk to your healthcare team for more information.
If you get a vaccine that requires 2 doses, you will have some protection after the first dose. You need the second dose for more protection, and a third dose for better protection.
Depending on cancer type and treatment, some people may not get as much protection from a vaccine as other people. But any amount of protection will keep you safer than none. We don’t know yet if some people with cancer will need to get a vaccine again after they finish treatment. More studies are needed to know how well the vaccines work for people with cancer.
The most common side effects from the COVID-19 vaccines are:
- fatigue (tiredness)
- muscle aches
- soreness where you got the vaccine
- redness and swelling where you got the vaccine
- joint pain
- a mild fever
- swollen glands (this happens less often)
If you get a vaccine that has 2 doses, these side effects are more likely to happen after the second dose.
In either case – if you have any lymphedema or have had a lymph node dissection – make sure you tell the people working at the vaccination site.
Currently, 4 COVID-19 vaccines are authorized for use in Canada:
- The Pfizer-BioNTech (Comirnaty) vaccine is approved for people 5 years of age and older.
- The Moderna (Spikevax) vaccine is approved for people 12 years of age and older.
- The AstraZeneca (Vaxzevria) vaccine is approved for people 18 years of age and older.
- The Janssen (Johnson & Johnson) vaccine is approved for people 18 years of age and older.
There are 2 types of approved COVID-19 vaccines: mRNA vaccines and viral vector-based vaccines. Neither vaccine type uses the live virus that causes COVID-19.
COVID-19 mRNA vaccines teach our cells how to make the spike protein on the COVID-19 virus that will trigger an immune response. Once triggered, our body then makes antibodies to help fight the infection if the real virus enters our body in the future. Find out more about mRNA vaccines for COVID-19.
Viral vector-based vaccines use a harmless virus as a delivery system. The vector virus used is not the virus that causes COVID-19. Once injected into the body, the virus contained within the vaccine produces the SARS-CoV-2 spike protein. Through this process, the body is able to mount a strong immune response against the spike protein without exposing you to the virus that causes COVID-19. Find out more about viral vector-based vaccines for COVID-19.
The Pfizer-BioNTech and Moderna COVID-19 vaccines are both mRNA vaccines. The AstraZeneca and Janssen COVID-19 vaccines are both viral vector-based vaccines for COVID-19. Talk to your healthcare team about which vaccine is best for you.
• The COVID-19 virus is similar to other viruses. Researchers already knew a lot about these types of viruses.
• Scientists around the world started to work on the vaccines right away when the COVID-19 virus was first found.
• Scientists around the world shared information with each other.
• Researchers were able to sign up a large number of people in clinical trials very quickly to test the vaccines. For example, over 200,000 people in the UK took part in clinical trials for COVID-19 vaccines.
Experts do not know how long antibodies last after someone has had COVID-19. A vaccine may help your body fight a future COVID-19 infection. Talk to your healthcare team about when you should get a vaccine after you recover.
How is the vaccine being rolled out in my province or territory? When should I get my doses? @(Model.HeadingTag)>
Talk to your healthcare team about the best timing for you to receive each of your vaccine doses, based on your unique circumstance.
Provinces and territories are rolling out vaccines differently. Check your eligibility for each of your doses on your provincial or territorial government’s website. Contact them if you have any questions or concerns.
- British Columbia
- New Brunswick
- Newfoundland and Labrador
- Northwest Territories
- Nova Scotia
- Prince Edward Island
What has CCS done to advocate for people with cancer to be prioritized to receive the COVID-19 vaccine? @(Model.HeadingTag)>
The COVID-19 vaccine has helped make the world safer for everyone, including people with cancer and cancer survivors. We know that people with cancer may be at risk for more serious outcomes of COVID-19, which is why we advocated to governments to make sure that Canadians with cancer were prioritized as vaccines rolled out.
CCS strives to be the voice for Canadians affected by cancer. We asked governments to:
- clearly identify when people with cancer and survivors will be vaccinated
- prioritize people with cancer and survivors with others who are at risk of more severe disease, and ensure that they have access to the first, second and additional doses of the vaccine before the general population
- support more research and monitoring of the outcomes of COVID-19 vaccines for people with cancer and survivors
- empower healthcare providers to determine the best timing of all doses for their patients based on their unique circumstances
- make vaccination of healthcare workers mandatory across all public and private settings
- implement strategies that decrease barriers to accessing vaccines including those faced by underserved and racialized communities
We will continue to advocate for important issues facing Canadians affected by cancer, which include timely access to vaccines for high-risk and vulnerable populations. We will also continue to call on governments to make information more accessible and broadly known.
I need help with a personal situation or unique circumstance related to cancer and the pandemic. How can CCS help me? @(Model.HeadingTag)>
We have free and confidential services available to help you find community and connection from the comfort of your home. You can connect with us and others across the country through CancerConnection.ca or call our toll-free Cancer Information Helpline at 1-888-939-3333. We also have cancer and COVID-19 resources available.
I have concerns about the vaccine rollout. How can I make my voice heard? @(Model.HeadingTag)>
Sharing your concerns directly with your elected officials is one of the best things you can do to hold them accountable and ensure they know the vaccine rollout is important to their constituents. You can find your local representative in our key contacts list.
We also have a dedicated volunteer group for advocacy called CCS Voices For Change. You can sign up to get more information and help us support people with cancer through the pandemic.
What is CCS doing to advocate for people with cancer during the pandemic? @(Model.HeadingTag)>
Is CCS partnering with other organizations to help people stay safe during COVID-19 and get vaccinated? @(Model.HeadingTag)>
CCS has partnered with 19 To Zero, a group of academics, public health experts, behavioural economists and creative professionals that are dedicated to promoting safe behaviour and vaccinations during COVID-19. CCS and 19 To Zero are united against COVID-19 and know that vaccinations save lives.
Find out more about 19 To Zero.